Health Care·Health Care Supplies·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | +35.54% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.62 | N/A | +35.54% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the earnings beat, highlighting their commitment to improving operational efficiencies. They maintained a cautious outlook without providing specific guidance.
We are pleased with our EPS performance this quarter.
Our focus remains on driving operational efficiencies.
The strong EPS performance indicates that Haemonetics Corp is managing its costs effectively and generating better profits than expected. The stock's 9.35% increase reflects investor confidence following this positive surprise. However, the lack of revenue data and forward guidance may leave some investors cautious about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
FORTINET INC
Feb 5, 2018